Patent details
EP1827409 Title: RASAGILINE ORALLY DISINTEGRATING COMPOSITIONS
Basic Information
- Publication number:
- EP1827409
- PCT Application Number:
- PCT/US/2005/041882
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP058518291
- PCT Publication Number:
- WO/2006/057912
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- RASAGILINE ORALLY DISINTEGRATING COMPOSITIONS
- French Title of Invention:
- COMPOSITIONS DE RASAGILINE DELITANTES ORALEMENT
- German Title of Invention:
- IM MUND ZERFALLENDE ZUSAMMENSETZUNGEN VON RASAGILIN
- SPC Number:
Dates
- Filing date:
- 17/11/2005
- Grant date:
- 24/08/2011
- EP Publication Date:
- 24/08/2011
- PCT Publication Date:
- 01/06/2006
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 05/09/2007
- EP B1 Publication Date:
- 24/08/2011
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 17/11/2011
- Expiration date:
- 17/11/2025
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 17/11/2005
- Name:
- TEVA PHARMACEUTICAL INDUSTRIES LTD.
- Address:
- 5 Basel Street, P.O. Box 3190, 49131 Petach-Tikva, Israel (IL)
Inventor
1
- Name:
- LICHT Daniella
- Address:
- Israel (IL)
2
- Name:
- GILBERT Adrian
- Address:
- Israel (IL)
3
- Name:
- PATASHNIK Shulamit
- Address:
- Israel (IL)
Priority
1
- Priority Number:
- 630918 P
- Priority Date:
- 24/11/2004
- Priority Country:
- United States (US)
2
- Priority Number:
- 997785
- Priority Date:
- 24/11/2004
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/135;
| Filing date | Document type | Number of pages |
|---|